Medical Technology Stock Letter
Medical Technology Stock Letter ... Recent commentaries about MTSL: Recent MTSL Topics: Investment Letter of the Year: Big Bio--All in the Family
http://www.bioinvest.com/
|
Medical Technology Stock Letter
BTK: 541.81, NBI: 622.71 . The world economy is in such dire straits, it feels futile to even discuss a sub-sector such as biotech. The equity markets are basically being ...
http://www.bioinvest.com/FrontEnd/index.asp
|
Is medical technology stock letter about to Matterhorn again ...
NEW YORK (MarketWatch) -- Difficult day, but one letter is making progress. And, on past form, that progress may accelerate.
http://www.marketwatch.com/news/story/medical-technology-stock-letter-about/story.aspx?guid=%7B29B04FD6%2D03BF%2D4D73%2D9575%2D44AD3849923D%7D&siteid=yhoof
|
The Medical Technology Stock Letter
The online investor's link to the financial newsletter community. ... The Medical Technology Stock Letter offers the premier coverage of investment opportunities in ...
http://www.financialnewsletters.com/adcorn/med.shtml
|
Investment Strategy & Growth Stocks | Value-Stock-Plus
Explained herein context to Biotechnology stocks as published in Medical Technology Stock Newsletter) The Medical Technology Stock Letter believes in the
http://www.valuestockplus.net/2005/11/investment-strategy-growth-stocks.html
|
Stock Picks, Investment Research - Free Stock Report
Tom & David Gardner, The Motley Fool; Jim Trippon, China Stock Digest; Mark Skousen, Forecasts & Strategies; John McCamant, Medical Technology Stock Letter; Gordon Pape, The Canada Report ...
http://topstockgurus.com
|
Bet along with Ichan on Biogen (BIIB) - BloggingStocks
In his Medical Technology Stock Letter, the advisor has long been a fan of Biogen Idec (NASDAQ: BIIB). Now, he is joined by Carl Ichan, who has purchased shares in the biotech firm.
http://www.bloggingstocks.com/2007/08/24/bet-along-with-ichan-on-biogen-biib/
|
Amylin (AMLN): 'Blockbuster potential' in diabetes - BloggingStocks
Following a presentation by the firm's CEO at a biotech conference, the editor of The Medical Technology Stock Letter concludes, "Management has made a compelling case why the stock ...
http://www.bloggingstocks.com/2007/09/18/amylin-amln-blockbuster-potential-in-diabetes/
|
Bird Flu High Flyer - Forbes.com
In the September issue of Medical technology Stock Letter, McCamant says "recent testing has shown that a single intramuscular injection of peramivir is comparable to, or better ...
http://www.forbes.com/newsletter/2005/10/12/biocryst-gilead-jnj-cz_jd_1012gurusow_inl.html
|
2 Penny, Stock Tips, Investing Analysis - Stock Market Gurus
Tom & David Gardner, The Motley Fool; Jim Trippon, China Stock Digest; Mark Skousen, Forecasts & Strategies; John McCamant, Medical Technology Stock Letter; Gordon Pape, The Canada Report ...
http://www.topstockgurus.com/indexb.php?kw=2%20Penny
|
